These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 29855382)
61. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Van Deerlin VM; Sleiman PM; Martinez-Lage M; Chen-Plotkin A; Wang LS; Graff-Radford NR; Dickson DW; Rademakers R; Boeve BF; Grossman M; Arnold SE; Mann DM; Pickering-Brown SM; Seelaar H; Heutink P; van Swieten JC; Murrell JR; Ghetti B; Spina S; Grafman J; Hodges J; Spillantini MG; Gilman S; Lieberman AP; Kaye JA; Woltjer RL; Bigio EH; Mesulam M; Al-Sarraj S; Troakes C; Rosenberg RN; White CL; Ferrer I; Lladó A; Neumann M; Kretzschmar HA; Hulette CM; Welsh-Bohmer KA; Miller BL; Alzualde A; Lopez de Munain A; McKee AC; Gearing M; Levey AI; Lah JJ; Hardy J; Rohrer JD; Lashley T; Mackenzie IR; Feldman HH; Hamilton RL; Dekosky ST; van der Zee J; Kumar-Singh S; Van Broeckhoven C; Mayeux R; Vonsattel JP; Troncoso JC; Kril JJ; Kwok JB; Halliday GM; Bird TD; Ince PG; Shaw PJ; Cairns NJ; Morris JC; McLean CA; DeCarli C; Ellis WG; Freeman SH; Frosch MP; Growdon JH; Perl DP; Sano M; Bennett DA; Schneider JA; Beach TG; Reiman EM; Woodruff BK; Cummings J; Vinters HV; Miller CA; Chui HC; Alafuzoff I; Hartikainen P; Seilhean D; Galasko D; Masliah E; Cotman CW; Tuñón MT; Martínez MC; Munoz DG; Carroll SL; Marson D; Riederer PF; Bogdanovic N; Schellenberg GD; Hakonarson H; Trojanowski JQ; Lee VM Nat Genet; 2010 Mar; 42(3):234-9. PubMed ID: 20154673 [TBL] [Abstract][Full Text] [Related]
62. Membrane orientation and subcellular localization of transmembrane protein 106B (TMEM106B), a major risk factor for frontotemporal lobar degeneration. Lang CM; Fellerer K; Schwenk BM; Kuhn PH; Kremmer E; Edbauer D; Capell A; Haass C J Biol Chem; 2012 Jun; 287(23):19355-65. PubMed ID: 22511793 [TBL] [Abstract][Full Text] [Related]
63. Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice. Klein ZA; Takahashi H; Ma M; Stagi M; Zhou M; Lam TT; Strittmatter SM Neuron; 2017 Jul; 95(2):281-296.e6. PubMed ID: 28728022 [TBL] [Abstract][Full Text] [Related]
64. Genetics of FTLD: overview and what else we can expect from genetic studies. Pottier C; Ravenscroft TA; Sanchez-Contreras M; Rademakers R J Neurochem; 2016 Aug; 138 Suppl 1():32-53. PubMed ID: 27009575 [TBL] [Abstract][Full Text] [Related]
66. The neuropathology associated with repeat expansions in the C9ORF72 gene. Mackenzie IR; Frick P; Neumann M Acta Neuropathol; 2014 Mar; 127(3):347-57. PubMed ID: 24356984 [TBL] [Abstract][Full Text] [Related]
67. Cortical iron accumulation in MAPT- and C9orf 72-associated frontotemporal lobar degeneration. Giannini LAA; Bulk M; Kenkhuis B; Rajicic A; Melhem S; Hegeman-Kleinn I; Bossoni L; Suidgeest E; Dopper EGP; van Swieten JC; van der Weerd L; Seelaar H Brain Pathol; 2023 Jul; 33(4):e13158. PubMed ID: 36974379 [TBL] [Abstract][Full Text] [Related]
68. Long-read sequencing across the C9orf72 'GGGGCC' repeat expansion: implications for clinical use and genetic discovery efforts in human disease. Ebbert MTW; Farrugia SL; Sens JP; Jansen-West K; Gendron TF; Prudencio M; McLaughlin IJ; Bowman B; Seetin M; DeJesus-Hernandez M; Jackson J; Brown PH; Dickson DW; van Blitterswijk M; Rademakers R; Petrucelli L; Fryer JD Mol Neurodegener; 2018 Aug; 13(1):46. PubMed ID: 30126445 [TBL] [Abstract][Full Text] [Related]
69. Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations. Marian OC; Teo JD; Lee JY; Song H; Kwok JB; Landin-Romero R; Halliday G; Don AS Acta Neuropathol Commun; 2023 Mar; 11(1):52. PubMed ID: 36967384 [TBL] [Abstract][Full Text] [Related]
70. p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR). Maor-Nof M; Shipony Z; Lopez-Gonzalez R; Nakayama L; Zhang YJ; Couthouis J; Blum JA; Castruita PA; Linares GR; Ruan K; Ramaswami G; Simon DJ; Nof A; Santana M; Han K; Sinnott-Armstrong N; Bassik MC; Geschwind DH; Tessier-Lavigne M; Attardi LD; Lloyd TE; Ichida JK; Gao FB; Greenleaf WJ; Yokoyama JS; Petrucelli L; Gitler AD Cell; 2021 Feb; 184(3):689-708.e20. PubMed ID: 33482083 [TBL] [Abstract][Full Text] [Related]
71. Peripheral inflammatory markers and clinical correlations in patients with frontotemporal lobar degeneration with and without the C9orf72 repeat expansion. Katisko K; Solje E; Korhonen P; Jääskeläinen O; Loppi S; Hartikainen P; Koivisto AM; Kontkanen A; Korhonen VE; Helisalmi S; Malm T; Herukka SK; Remes AM; Haapasalo A J Neurol; 2020 Jan; 267(1):76-86. PubMed ID: 31559531 [TBL] [Abstract][Full Text] [Related]
72. C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci. Mizielinska S; Lashley T; Norona FE; Clayton EL; Ridler CE; Fratta P; Isaacs AM Acta Neuropathol; 2013 Dec; 126(6):845-57. PubMed ID: 24170096 [TBL] [Abstract][Full Text] [Related]
73. Recent advances in the genetics of the ALS-FTLD complex. Morris HR; Waite AJ; Williams NM; Neal JW; Blake DJ Curr Neurol Neurosci Rep; 2012 Jun; 12(3):243-50. PubMed ID: 22477152 [TBL] [Abstract][Full Text] [Related]
74. Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteins. Davidson Y; Robinson AC; Liu X; Wu D; Troakes C; Rollinson S; Masuda-Suzukake M; Suzuki G; Nonaka T; Shi J; Tian J; Hamdalla H; Ealing J; Richardson A; Jones M; Pickering-Brown S; Snowden JS; Hasegawa M; Mann DM Neuropathol Appl Neurobiol; 2016 Apr; 42(3):242-54. PubMed ID: 26538301 [TBL] [Abstract][Full Text] [Related]
75. C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation. Josephs KA; Zhang YJ; Baker M; Rademakers R; Petrucelli L; Dickson DW Acta Neuropathol Commun; 2019 Jul; 7(1):100. PubMed ID: 31266542 [TBL] [Abstract][Full Text] [Related]
76. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ciura S; Lattante S; Le Ber I; Latouche M; Tostivint H; Brice A; Kabashi E Ann Neurol; 2013 Aug; 74(2):180-7. PubMed ID: 23720273 [TBL] [Abstract][Full Text] [Related]
77. What we know about TMEM106B in neurodegeneration. Nicholson AM; Rademakers R Acta Neuropathol; 2016 Nov; 132(5):639-651. PubMed ID: 27543298 [TBL] [Abstract][Full Text] [Related]
78. Jump from pre-mutation to pathologic expansion in C9orf72. Xi Z; van Blitterswijk M; Zhang M; McGoldrick P; McLean JR; Yunusova Y; Knock E; Moreno D; Sato C; McKeever PM; Schneider R; Keith J; Petrescu N; Fraser P; Tartaglia MC; Baker MC; Graff-Radford NR; Boylan KB; Dickson DW; Mackenzie IR; Rademakers R; Robertson J; Zinman L; Rogaeva E Am J Hum Genet; 2015 Jun; 96(6):962-70. PubMed ID: 26004200 [TBL] [Abstract][Full Text] [Related]
79. Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Almeida S; Gascon E; Tran H; Chou HJ; Gendron TF; Degroot S; Tapper AR; Sellier C; Charlet-Berguerand N; Karydas A; Seeley WW; Boxer AL; Petrucelli L; Miller BL; Gao FB Acta Neuropathol; 2013 Sep; 126(3):385-99. PubMed ID: 23836290 [TBL] [Abstract][Full Text] [Related]
80. Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation. Galimberti D; Fenoglio C; Serpente M; Villa C; Bonsi R; Arighi A; Fumagalli GG; Del Bo R; Bruni AC; Anfossi M; Clodomiro A; Cupidi C; Nacmias B; Sorbi S; Piaceri I; Bagnoli S; Bessi V; Marcone A; Cerami C; Cappa SF; Filippi M; Agosta F; Magnani G; Comi G; Franceschi M; Rainero I; Giordana MT; Rubino E; Ferrero P; Rogaeva E; Xi Z; Confaloni A; Piscopo P; Bruno G; Talarico G; Cagnin A; Clerici F; Dell'Osso B; Comi GP; Altamura AC; Mariani C; Scarpini E Biol Psychiatry; 2013 Sep; 74(5):384-91. PubMed ID: 23473366 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]